Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 39
Selected: 0
NCT IDTitle
NCT04498182A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT02558374Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT04401982Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
NCT05360966Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)
NCT03310580Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
NCT04620135Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT0133097924-hour Efficacy of AR-12286
NCT02207491Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01474135AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
NCT01789736A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
NCT04064918Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity
NCT02874846Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution
NCT04498169A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
NCT05285644Study Evaluating the Safety and Efficacy of AR-15512
NCT00523250Ocular Hypotensive Efficacy of AR-102
NCT05283395Rocklatan® Evaluation
NCT03233308Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01060579Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
NCT01997879Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers
NCT02057575Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
NCT01302249AR-12286 in Combination With Latanoprost
NCT00902200A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)
NCT05497479Study Evaluating Techniques for Measuring Tear Production
NCT03808688Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
NCT02558400Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT03835884A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
NCT01699464A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
NCT02207621Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension
NCT02246764Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01731002Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
NCT03739593Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
NCT02406287A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers
NCT02674854Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT01528787Study of AR-13324 in Patients With Elevated Intraocular Pressure
NCT01250197Formulation Comparison in Normal Volunteers
NCT05493111A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512
NCT03844945Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan
NCT05769153Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT03284853Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension